{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:52:25Z","timestamp":1783633945583,"version":"3.55.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,5,1]]},"abstract":"<jats:p>Familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia type 2A syndromes are dominantly inherited diseases caused by activating germline mutations of the RET protooncogene. The majority of these patients carry a germline point mutation affecting one of five cysteine residues encoded by exon 10 (codon 609, 611, 618, or 620) or 11 (codon 634). In a few FMTC families, point mutations involving noncysteine codons in exon 13 (codons 768, 790, and 791), 14 (codon 804), or 15 (codon 891) have been reported. Hirschsprung\u2019s disease is a nonneoplastic disorder associated with RET mutations leading to a loss of function effect. Mutations are identified in 50% of the familial cases and are scattered along the gene. We now report the study of a FMTC family with four affected members and a history of fatal neonatal intestinal obstruction in the sister of the proband. Genetic analysis demonstrated the absence of an usual FMTC mutation and the presence of a germline 9-bp duplication in RET exon 8 in the heterozygous state in all patients with MTC. This new mutation creates an additional cysteine residue in the extracellular cysteine-rich domain of RET. Further studies are warranted to confirm whether this new mutation is causing MTC only or could be associated with Hirschsprung\u2019s disease.<\/jats:p>","DOI":"10.1210\/jcem.84.5.5665","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:04:37Z","timestamp":1389200677000},"page":"1700-1704","source":"Crossref","is-referenced-by-count":1,"title":["A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma1"],"prefix":"10.1210","volume":"84","author":[{"given":"Pascal","family":"Pigny","sequence":"first","affiliation":[{"name":"Laboratoire de Biochimie-Secteur commun de Biologie Mole\u0301culaire de l\u2019Ho\u0302pital Huriez (P.P., M.C., M.P.B., J.P.K., N.P.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bauters","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie & Me\u0301decine Interne (C.B., J.L.W.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Wemeau","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie & Me\u0301decine Interne (C.B., J.L.W.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Lecomte Houcke","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie Pathologique A (M.L.H.), Centre Hospitalier Re\u0301gional Universitaire, 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Crepin","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie-Secteur commun de Biologie Mole\u0301culaire de l\u2019Ho\u0302pital Huriez (P.P., M.C., M.P.B., J.P.K., N.P.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Caron","sequence":"additional","affiliation":[{"name":"Service d\u2019Endocrinologie, Ho\u0302pital de Rangueil, Centre Hospitalier Universitaire (P.C.), F-31403 Toulouse Cedex 4, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Giraud","sequence":"additional","affiliation":[{"name":"Laboratoire de Ge\u0301ne\u0301tique Mole\u0301culaire, Ho\u0302pital Edouard Herriot (S.G., A.C.), F-69437 Lyon Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Calender","sequence":"additional","affiliation":[{"name":"Laboratoire de Ge\u0301ne\u0301tique Mole\u0301culaire, Ho\u0302pital Edouard Herriot (S.G., A.C.), F-69437 Lyon Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Buisine","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie-Secteur commun de Biologie Mole\u0301culaire de l\u2019Ho\u0302pital Huriez (P.P., M.C., M.P.B., J.P.K., N.P.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Kerckaert","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie-Secteur commun de Biologie Mole\u0301culaire de l\u2019Ho\u0302pital Huriez (P.P., M.C., M.P.B., J.P.K., N.P.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Porchet","sequence":"additional","affiliation":[{"name":"Laboratoire de Biochimie-Secteur commun de Biologie Mole\u0301culaire de l\u2019Ho\u0302pital Huriez (P.P., M.C., M.P.B., J.P.K., N.P.), 59037 Lille Cedex"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071619042867100_R1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2362.1996.tb02144.x","article-title":"RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspects.","volume":"26","author":"Ho\u0308ppener","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"2020071619042867100_R2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/381789a0","article-title":"GDNF signalling through the Ret receptor tyrosine kinase.","volume":"381","author":"Durbec","year":"1996","journal-title":"Nature"},{"key":"2020071619042867100_R3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/42722","article-title":"A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor.","volume":"387","author":"Klein","year":"1997","journal-title":"Nature"},{"key":"2020071619042867100_R4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1242\/dev.119.4.1005","article-title":"Expression of the c-ret protooncogene during mouse embryogenesis.","volume":"119","author":"Pachnis","year":"1993","journal-title":"Development"},{"key":"2020071619042867100_R5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.41.4.436","article-title":"Hirschsprung\u2019s disease: genetic mutations in mice and men.","volume":"41","author":"Robertson","year":"1997","journal-title":"Gut"},{"key":"2020071619042867100_R6","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/MCB.15.3.1613","article-title":"Mechanism of activation of the ret proto oncogene by MEN 2A mutations.","volume":"15","author":"Asai","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2020071619042867100_R7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B.","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"2020071619042867100_R8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ng0595-35","article-title":"Loss of function effect of RET mutations causing Hirschsprung disease.","volume":"10","author":"Pasini","year":"1995","journal-title":"Nat Genet"},{"key":"2020071619042867100_R9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI375","article-title":"Various mechanisms cause RET-mediated signaling defects in Hirschprung\u2019s disease.","volume":"101","author":"Pelet","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071619042867100_R10","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jcem.82.11.4508","article-title":"Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in MEN 2B without codon 918 mutation.","volume":"82","author":"Gimm","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619042867100_R11","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in MEN 2. International RET Mutation Consortium Analysis.","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"2020071619042867100_R12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4065\/72.5.430","article-title":"Genetic testing in MTC syndromes: mutation types and clinical significance.","volume":"72","author":"Heshmati","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"2020071619042867100_R13","first-page":"509","article-title":"A novel point mutation in the TK domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.","volume":"10","author":"Eng","year":"1995","journal-title":"Oncogene"},{"key":"2020071619042867100_R14","first-page":"2415","article-title":"RET mutations in exons 13 and 14 in FMTC patients.","volume":"10","author":"Bolino","year":"1995","journal-title":"Oncogene"},{"key":"2020071619042867100_R15","first-page":"4176","article-title":"A novel point mutation in the intracellular domain of the ret protooncogene in a family with MTC.","volume":"82","author":"Hofstra","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619042867100_R16","first-page":"770","article-title":"A new hot spot for mutations in the ret protooncogene causing FMTC and MEN 2A.","volume":"83","author":"Berndt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619042867100_R17","first-page":"114","article-title":"Pentagastrin stimulation test and early diagnostic of MTC using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary MTC.","volume":"78","author":"Barbot","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619042867100_R18","author":"Wright","year":"1990"},{"key":"2020071619042867100_R19","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/3.11.1939","article-title":"RET proto-oncogene mutations in french MEN 2A and FMTC families.","volume":"3","author":"Schuffenecker","year":"1994","journal-title":"Hum Mol Genet"},{"key":"2020071619042867100_R20","first-page":"1257","volume":"10","author":"Ceccherini","journal-title":"DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene [and erratum in Oncogene"},{"key":"2020071619042867100_R21","first-page":"2575","article-title":"Structural analysis of the human ret proto-oncogene using exon trapping.","volume":"8","author":"Kwok","year":"1993","journal-title":"Oncogene"},{"key":"2020071619042867100_R22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19950801)76:3<479::AID-CNCR2820760319>3.0.CO;2-M","article-title":"Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable MTC.","volume":"76","author":"Komminoth","year":"1995","journal-title":"Cancer"},{"key":"2020071619042867100_R23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/hmg\/4.8.1381","article-title":"Diversity of RET proto-oncogene mutations in familial and sporadic Hirchsprung disease.","volume":"4","author":"Attie\u0301","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071619042867100_R24","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/hmg\/4.5.821","article-title":"Mutation analysis of the RET receptor tyrosine kinase in Hirchsprung disease.","volume":"4","author":"Angrist","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2020071619042867100_R25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/7.1.129","article-title":"Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation.","volume":"7","author":"Decker","year":"1998","journal-title":"Hum Mol Genet"},{"key":"2020071619042867100_R26","first-page":"2731","article-title":"C618R mutation in exon 10 of the RET proto-oncogene in a kindred with MEN 2A and Hirschsprung\u2019s disease.","volume":"81","author":"Caron","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071619042867100_R27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/hmg\/6.4.587","article-title":"A duplication of 12bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of MEN 2A.","volume":"6","author":"Ho\u0308ppner","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2020071619042867100_R28","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/humu.1380110143","article-title":"Duplication of 9bp in the critical cysteine rich domain of the RET proto-oncogene causes MEN 2A","volume":"6","author":"Ho\u0308ppner","year":"1998","journal-title":"Hum Mutat."},{"key":"2020071619042867100_R29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.43.4.542","article-title":"Oncological implications of RET gene mutations in Hirchsprung\u2019s disease.","volume":"43","author":"Sijmons","year":"1998","journal-title":"Gut"},{"key":"2020071619042867100_R30","first-page":"2870","article-title":"Biological properties of Ret with cysteine mutations correlate with MEN 2A, FMTC and Hirschsprung \u2019s disease phenotype.","volume":"57","author":"Ito","year":"1997","journal-title":"Cancer Res"},{"key":"2020071619042867100_R31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.onc.1201199","article-title":"Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.","volume":"15","author":"Pasini","year":"1997","journal-title":"Oncogene"},{"key":"2020071619042867100_R32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/hmg\/5.10.1577","article-title":"Mechanism of Ret dysfunction by Hirschsprung mutations affecting its extracellular domain.","volume":"5","author":"Iwashita","year":"1996","journal-title":"Hum Mol Genet"},{"key":"2020071619042867100_R33","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/j.1460-2075.1996.tb00632.x","article-title":"Molecular heterogeneity of RET loss of function in Hirschsprung\u2019s disease.","volume":"15","author":"Carlomagno","year":"1996","journal-title":"EMBO J"},{"key":"2020071619042867100_R34","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1202202","article-title":"Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.","volume":"17","author":"Chappuis-Flament","year":"1998","journal-title":"Oncogene"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/5\/1700\/9215613\/jcem1700.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/5\/1700\/9215613\/jcem1700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:59:01Z","timestamp":1647907141000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/84\/5\/1700\/2864368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.84.5.5665","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5,1]]}}}